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Familial Hemiplegic Migraine and Episodic
Ataxia Type-2 Are Caused by Mutations
in the Ca21 Channel Gene CACNL1A4
Roel A. Ophoff,1,2 Gisela M. Terwindt,2 Introduction
Monique N. Vergouwe,1,2 Ronald van Eijk,1,2
Peter J. Oefner,3 Susan M. G. Hoffman,4,8 Migraine is a frequent, neurological disorder, character-
Jane E. Lamerdin,4 Harvey W. Mohrenweiser,4 ized by recurrent attacks of disabling headache, vom-
Dennis E. Bulman,5 Maurizio Ferrari,6 iting, photo- and phonophobia, and malaise (migraine
Joost Haan,2 Dick Lindhout,7 without aura). In 20% of patients, additional transient
Gert-Jan B. van Ommen,1 Marten H. Hofker,1 focal neurological (aura) symptoms may occur (migraine
Michel D. Ferrari,2 and Rune R. Frants1 with aura) (Headache Classification Committee, 1988).
1MGC—Department of Human Genetics Up to 24% of females and 12% of males in the general
Sylvius Laboratory population are affected by migraine, although fre-
Leiden University quency, duration, and severity of the attacks vary sub-
Wassenaarseweg 72 stantially across patients (Russell et al., 1995).
2333 AL Leiden Family, twin, and population-based studies suggest
2Department of Neurology that genetic factors are involved in migraine, most likely
Leiden University Hospital as part of a multifactorial mechanism (Russell and
Albinusdreef 2 Olesen, 1995; Haan et al., 1996). The complex genetics
2333 ZA Leiden has, thus far, hampered identification of candidate
The Netherlands genes. Familial hemiplegic migraine (FHM), a rare au-
3Department of Genetics tosomal dominant subtype of migraine with aura, is as-
Stanford University sociated with ictal hemiparesis and, in some families,
Stanford, California 94305 progressive cerebellar atrophy (Headache Classification
4Lawrence Livermore National Laboratory Committee, 1988; Terwindt et al., 1996). Otherwise, the
BBRP symptoms of the headache and aura phase of FHM and
Livermore, California 94550 “normal“ migraine attacks are very similar, and both
5Department of Clinical Neurological Sciences types of attack may alternate within individuals and co-
London Health Sciences Centre occur within families. FHM is thus part of the migraine
London, Ontario N6A 5A5 spectrum and can be used as a model to study the
Canada complex genetics of the more common forms of mi-
6Clinical Molecular Biology Laboratory graine.
IRCCS S. Raffaele A gene for FHM has been assigned to chromosome
Via Olgettina 60 19p13 in about 50% of the families tested (Joutel et
20132 Milan al., 1993; Ophoff et al., 1994, 1996; Joutel et al., 1994).
Italy
Cerebellar atrophy was found only in FHM families linked7MGC—Department of Clinical Genetics
to chromosome 19p13 (Terwindt et al., 1996). Recently,
Erasmus University Rotterdam
the region containing the 19p13 FHM locus was shown
3000 DR Rotterdam
to be also involved in the more common forms of mi-The Netherlands
graine (May et al., 1995), adding to the hypothesis that
FHM is part of the migraine spectrum involving similar
genetic factors and biological mechanisms.Summary
Episodic ataxia type 2 (EA-2) is another autosomal
dominant paroxysmal cerebral disorder, characterizedGenes for familial hemiplegic migraine (FHM) and epi-
by acetazolamide-responsive attacks of cerebellar atax-sodic ataxia type-2 (EA-2) have been mapped to chro-
ia and migraine-like symptoms, interictal nystagmus,mosome 19p13. We characterized a brain-specific
and cerebellar atrophy (Von Brederlow et al., 1995). Re-P/Q-type Ca21 channel a1-subunit gene, CACNL1A4,
cently, a locus for EA-2 was mapped to chromosomecovering 300 kb with 47 exons. Sequencing of all exons
19p13, in the same interval as the FHM locus (Kramerand their surroundings revealed polymorphic varia-
et al., 1995; Von Brederlow et al., 1995; Teh et al., 1995).tions, including a (CA)n-repeat (D19S1150), a (CAG)n-
This finding, in addition to the clinical similarities, raisesrepeat in the 39-UTR, and different types of deleterious
the possibility that EA-2 and FHM are allelic disorders.mutations in FHM and EA-2. In FHM, we found four
Since other hereditary acetazolamide-responsive epi-different missense mutations in conserved functional
sodic neurological disorders, such as hypokalemic anddomains. One mutation has occurred on two different
hyperkalemic periodic paralysis, as well as EA type-1,haplotypes in unrelated FHM families. In EA-2, we
have all been associated with mutations in ion channelfound two mutations disrupting the reading frame.
genes (Ptacek et al., 1991, 1994; Browne et al., 1994;Thus, FHM and EA-2 can be considered as allelic chan-
Jurkatt-Rott et al., 1994; Griggs and Nutt, 1995), wenelopathies. A similar etiology may be involved in com-
specifically searched for similar genes within the FHMmon types of migraine.
and EA-2 candidate region.
Using exon trapping, we identified a human cDNA,
highly related to a brain-specific rabbit and rat voltage8 Present address: Department of Zoology, Miami University, Oxford,
Ohio. gated P/Q-type Ca21 channel a1 subunit (Mori et al.,
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Figure 1. Genetic Map, Cosmid Contig, and Global Exon Distribution of the CACNL1A4 Gene on Chromosome 19p13.1
Cosmid contig is shown with EcoRI restriction sites, available via Lawrence Livermore National Laboratory (LLNL); exon positions are indicated
schematically, regardless of exon or intron sizes (Table 1). D19S1150 is a highly polymorphic intragenic (CA)n-repeat.
1991; Starr et al., 1991). The human gene was designated similarity (92%) (Margolis et al., 1995). The different frag-
ments of the cDNA sequences were amplified from totalCACNL1A4 (Diriong et al., 1995). The gene contains an
open reading frame that encodes a protein of 2261 human cerebellum cDNA (Clontech) by PCR and were
used as probes for screening the same cerebellum li-amino acids. Because of the brain-specific expression,
and its putative ion channel function, CACNL1A4 was brary (Clontech). Assembly of the complete coding se-
quence of the human cDNA showed an open readingconsidered an excellent candidate gene for FHM and
EA-2. The genomic structure was elucidated and muta- frame of 6783 nucleotides, which encodes for a putative
protein of 2261 amino acids (EMBL X99897). Recently,tion analysis was performed, applying single strand
conformational polymorphism (SSCP) and denaturing a neuronal Ca21 a1A-subunit gene was localized to chro-
mosome 19p13.1-p13.2 by FISH analysis (Diriong et al.,high-performance liquid chromatography (DHPLC). The
results indicate that missense mutations in the a1 sub- 1995). The gene symbol isCACNL1A4 and the a1 subunit
is classified as a P/Q-type. Although no sequence dataunit cause FHM, while truncating mutations in the same
protein cause EA-2. These findings imply that FHM, for the CACNL1A4 gene are available yet, the same
localization (chromosome 19p13.1) and the identicalEA-2, and possibly also the more common types of
migraine are ion channel disorders and provide yet an- classification (P/Q-type) strongly suggest that the Ca21
channel a1 subunit we have identified is CACNL1A4.other example in the growing list of ion channel disor-
ders in which remarkable phenotypic heterogeneity is
associated with different types and positions of muta-
Genomic Structuretions.
The cosmid contig that yielded the initial Ca21 channel
gene exons was extended tocover morethan 300 kb and
has been placed into the Lawrence Livermore NationalResults
Laboratory (LLNL) physical map of chromosome 19 at
band p13.1 (Figure 1). Initial hybridization experimentscDNA Sequence
Eight cosmids, forming two small contigs in the FHM showed that the first and the last cosmids of this contig
were positive for 39- and 59-end cDNA sequences, re-candidate region between markers D19S394 and
D19S226 (Figure 1), were subjected to exon trapping. spectively. Therefore, all 10 cosmids of the contig (Fig-
ure 1) were randomly subcloned. Subsequently, clonesFive different clones were identified, showing a highly
similar ($90%) sequence to rabbit (EMBL X57476) and containing exons were selected by hybridization using
overlapping CACNL1A4 cDNA probes (EMBL X99897)rat (Genbank M64373) cDNA, both encoding a brain-
specific P/Q-type Ca21 channel a1 subunit (Mori et al., and sequenced using vector- and exon-specific primers.
Complete alignment between the cDNA and individual1991; Starr et al., 1991). These clones most likely repre-
sented five adjacent exons of the human ortholog of the exon sequence was achieved, allowing establishment
of the exon–intron structure (Table 1). The CACNL1A4Ca21 channel gene from position 292 to 985 (positions
based on rat cDNA sequence). A BLAST search using gene is composed 47 exons ranging in size from 36 bp
(exon 44) to 810 bp (exon 19). Exon 1 includes the startthe 39-end of the rat cDNA (position 6000–6638) revealed
a human EST (GenBank U06702), again with very high codon and the untranslated 59 region. The stop codon,
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Table 1. Exon/Intron Organization of the Human CACNL1A4 Gene and Exon-Specific Primer Pairs
Exon cDNA Size Domain Cosmid(s) Primer Forward Primer Reversed Size
1 UTR–568 $500 25960/30151 tct ccg cag tcg tag ctc ca ggt tgt aga gtg cca tgg tc 320
cgc aaa gga tgt aca agc ag att ccc aag cct cca ggg tag 370
2 569–674 106 I S1 30151 cac ctc caa cac cct tct tt tct gtg ccc tgc tcc act c 240
3 675–814 140 I S2, I S3 30151 acg ctg acc ttg cct tct ct caa cca aaa gcc tcg taa tc 230
4 815–906 92 I S3, I S4 28913 aaa acc cac cct ctg ttc tc ttg tca ggg tcg gaa act ca 160
5 907–1059 153 I S5 28913/27415 ctt ggt ggc ggg gtt t ctg cct aat cct ccc aag ag 290
6 1060–1253 194 27415 tcc ctt ccc ttt tgt aga tg gtg ggg ctg tgt tgt cct t 350
7 1254–1357 104 I S6 27415 gac aga gcc aca aga gaa cc agc aaa gag gag tga gtg gg 250
8 1358–1473 116 34077/27415 ata ctc tgg ctt ttc tat gc gca tga ctc tct ttg tac tc 230
9 1474–1530 57 34077 gca gag aat ggg ggt gg ctg agg tgg gtt tag agc ag 180
10 1531–1623 93 34077 ggg taa cgt ctt ttt ctc ttg c atg tct ctt ggg cga tag gt 200
11 1624–1833 210 II S1 16894/32236 att tct tct gaa gga aca gc gga ggg atc agg gag ttg gc 310
12 1834–1946 113 II S2, II S3 16894 caa gcc taa cct cct ctc tg tca ttc cag gca aga gct g 200
13 1947–2051 105 II S3, II S4 16894 att tgg agg gag gag ttt gg tca ctt tcc caa ctt tct gg 310
14 2052–2191 140 II S4, II S5 16894 cag aaa gtt ggg aaa gta gc ttg aat tcc tgt gaa gga c 250
15 2192–2264 73 16894 ctt gga gat gag ata ctg agc cag gca ctt tca tct gtg ac 200
16 2265–2382 118 II S6 16894 tcc aca gct gca tct cca ag acc ctc cct tga gcc cct 270
17 2383–2450 68 II S6 16894 cag tgg ttg ctt ttc ctg ac ttg cca gag aaa cat tct cc 130
18 2451–2557 107 16894 tga aca aag att cca cgt gc ttc agg agc cag ggt agc atc 170
19 2558–3367 810 16894 tag caa tgc tct aag tcc tg tgt ttc ctg agg aag tcc tc 320
cgc agg aga acc gca aca a gcg atg acg tcg atg ctc 450
gc agc agg gag agc cgc agc tac cgt cat tct gcg gat tc 300
20 3368–3831 464 16894 ggt tct ttt tca ttc act tgc ttt cct ggc agt ctt agc tg 430
gag aat agc ctt atc gtc ac cag tga tgt gag agc aga g 200
21 3832–3973 142 16894/34275 tgg gaa att gtg gag gga gc tga ctt ccg cca ccc tgg tg 250
22 3974–4103 130 III S1 16894/34275 agc ctg tgg tct gag tgg ac tag gaa ggg gtg tgc tct gtg 210
23 4104–4163 60 III S2, III S3 16894/34275 atc cac tgc tct ctt gct tt gtg gtt ctc act tat aat ctg c 170
24 4164–4270 107 III S3 34275 tgg cct cat tgg ctt ccc tgc aag agg aaa ccc ttg cga ag 250
25 4271–4370 100 III S4 34275 cta ccc aac ctg acc tct gc aca tga taa ccc tga cag tc 220
26 4371–4531 161 III S5 34275 ctc atg ctc tct gtc aac tc tgg ttc caa tgg gaa tgt gc 250
27 4532–4669 138 34275 ctg ctt ccc aag cag tct ag tcc tgg ata gat ttc cag tc 300
28 4670–4871 202 III S6 34275 agt ttt taa agg aca gat gg ttt ccc tgc ccc att cct ttg c 280
29 4872–5036 165 IV S1 34275 ctc tgc cgc tct cac cac tg ttt atc agg tag agg cag g 250
30 5037–5147 111 IV S1, IV S2 34275 ttc caa gcc cat agc tgt agc tga ccc tgc tac tcc tgc ttc 180
31 5148–5231 84 IV S3 15496 act gtg cct cta aca tgc ac aag tgc tgg ctc aag cag 250
32 5232–5348 117 IV S4 15496 tct gtg agt ggt gac agc tc gtc acc tgt ctt ctc agc 240
33 5349–5414 66 IV S5 15496 tgg aag gac tct ggc acg tg gga ggc tct ggg aac ctt ag 250
34 5415–5530 116 15496 aga agc cac tgg agg aat ggc att atc aga gca ggt ccc ctt c 250
35 5531–5681 151 IV S6 15496 tcc gag tct ctg att tct cc aga cgg ccc tca cag tgt c 210
36 5682–5809 128 IV S6 15496 ttc att ccc tcg gtc tct gc ctg act gaa cct gtg aga c 350
37 5810–5906 97 15496 tgt gaa ccc att gcc tgc a tgg gaa tga ctg cgc ttg c 200
38 5907–6012 106 15496 atg cct ggg aat gac tgc tgt cac gcc tgt ctg tgc 200
39 6013–6120 108 15496 tga cac cca ggc agg cag tct gtc ctg gtg gat tgg atc 200
40 6121–6221 101 15496 ttg gtg agc tca ccg tgt ttc ccg tgg tga cat gca agc 200
41 6222–6331 110 15496 gtc cac aca ctg ctc tct gc aca ctc cac ctc cct ggc 320
42 6332–6470 139 15496 gcc agg gag gtg gag tgt ggt tcc ttc cac cgc aac 550
43 6471–6584 114 15496/30762 caa ctc ccc aat ggc tc cct acc cag tgc aga gtg agg 350
44 6585–6620 36 15496/30762 tct gtg tgc acc atc cca tg aag gat tgg gct cca tgg ag 200
45 6621–6807 187 15496/30762 gtt ggt gct agc tgc tga c ctt tct tct tcc tta gtg tc 330
46 6808–7061 254 15496/30762 gtg tgc tgt ctg acc ctc ac agc ctg ggg tca ctt gca gc 320
47 7062–UTR $350 30762 cct ttg ttt caa ttt tcg tgt ag tgg ggc ctg ggt acc tcc ga 280
Sizes of exons and PCR products are given in basepairs; cDNA and genomic sequences are available via EMBL accession no. X99897,
Z80114–Z80115, respectively; domains of protein are indicated according to Stea et al., 1995.
as well as the 39-terminal noncoding region, is located a (CA)-repeat sequence, which turned out to be highly
polymorphic (D19S1150). Analysis of this dinucleotidein exon 47. The exons are distributed over z300 kb DNA.
The first 10 exons span z150 kb and are covered by repeat revealed nine alleles with an observed heterozy-
gosity of 0.82, in 45 random individuals from the Dutchthe first 5 cosmids of the contig (Table 1; Figure 1),
which indicates relatively large introns at the 59 side of population. Sequences of all exons and flanking introns
are available via EMBL accession numbers Z80114–the gene. Sequence data was obtained for every exon
and z100 bp of flanking introns, except for the 59 end Z80115.
of exon 6. Therefore, the forward primer of exon 6 con-
tains the splice junction and 3 bp of exon 6. Splice Northern Blot Analysis
In an initial Northern blot analysis, the spatial distributionsites flanking all exons are compatible with consensus
sequence with the exception of the splice donor and of the human CACNL1A4 expression was assayed in
rhesus monkey tissues. Total RNA was isolated fromacceptor of the first intron. Sequence of intron 7 showed
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membrane spanning segments (S1–S6) of domains I–IV
are most similar between different classes of Ca21 chan-
nel a1 subunits (Stea et al., 1995) and enabled us to
predict the putative membrane topology of CACNL1A4
as shown in Table 1 and Figure 3.
Mutation Analysis
All 47 exons and flanking intron sequences were
screened for the presence of mutations by SSCP and
DHPLC analysis in 20 individuals with either FHM or
EA-2. Several synonymous nucleotide substitutions and
polymorphisms, including a highly polymorphic (CAG)n-
repeat in the 39 untranslated region of exon 47, were
identified by their occurrence in unaffected controls and
lack of cosegregation with the disease in families (Table
Figure 2. Expression of Human P/Q-Type Calcium Channel a1-Sub- 2). Only the polymorphism in exon 11 predicts an amino
unit Gene (CACNL1A4) Tested in Different Tissues acid change, an alanine-to-threonine substitution at co-
Northern blot of total RNA from rhesus monkey tissues (total brain, don 454 (A454T).
cerebellum, cortex, hypothalamus, muscle, heart, kidney, liver), hu-
Four different missense mutations were identified inman lymphocytes, and mouse skin, hybridized with human cDNA
FHM patients of which one mutation was observed inprobe 1 (See cDNA Sequence section of Experimental Procedures).
two unrelated FHM-affected individuals (Table 3; FigureSize of transcript was estimated at 9.8 kb.
4). The mutations were shown to segregate with the
disease in thecorresponding families and were not pres-
ent in 100 control chromosomes. A transition from G toseveral tissues, including various brain structures, and
probed with a human cDNA fragment (Figure 2). The A was identified in family It-II at codon 192, resulting in
a substitution of arginine for glutamine (R192Q) withinprobe detected a major transcript of approximately 9.8
kb in cerebellum, cerebral cortex, thalamus and hypo- the fourth segment of the first membrane spanning do-
main (IS4). A second missense mutation occurs at codonthalamus, whereas no transcript was detected in heart,
kidney, liver, or muscle. There was also no hybridization 666, within the hairpin loop of the second repeat, replac-
ing a threonine residue for methione (T666M) in familysignal found in RNA preparations from mouse skin tissue
or from human peripheral lymphocytes. US-P. Two other mutationswere located in the 6th trans-
membrane spanning segment of repeats II and IV. The
IIS6 mutation is a T-to-C transition at codon 714, re-Primary Structure of CACNL1A4
Calcium channels are multimeric complexes that are sulting in a valine-to-alanine substitution (V714A), and
was identified in FHM family UK-B. The mutation in do-composed of one a1, a2, d, and a b subunit (Campbell
et al., 1988). The central a1 subunit is functionally the main IVS6 was an A-to-C transversion at codon 1811
that resulted in a substitution of isoleucine for leucinemost important component and acts as a voltage sensor
and forms the ion-conducting pore. The other subunits (I1811L). This I1811L mutation was found twice, in family
NL-A and family US-C, which are two unrelated FHMhave auxiliary regulatory roles. Topologically, an a1 sub-
unit consists of four internal homologous repeats (I–IV), families. Moreover, comparison of haplotypes in this
region, including intragenic markers, indicated recurrenteach containing six putative a-helical membrane span-
ning segments (S1–S6) and one pore-forming (P) seg- mutations on two genetically distinguishable chromo-
somes (data not shown).ment between S5-S6 that spans only the outer part of
the transmembrane region (Guy and Durell, 1996). The In addition to missense mutations in FHM families,
Figure 3. Membrane Topology of a1 Subunit
of the P/Q-Type Ca21-Channel, CACNL1A4
The location and amino acid substitutions are
indicated for mutations that cause familial
hemiplegic migraine (FHM) and episodic
ataxia type-2 (EA-2).
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Table 2. Polymorphisms in Coding Sequence of CACNL1A4
Nucleotide Change
Location Frequency Consequence
Exon 4 nt 854 G→A Thr193 0.02 —
Exon 6 nt 1151 A→G Glu292 0.07 —
Exon 8 nt 1457 G→A Glu394 0.38 —
Exon 11 nt 1635 G→A Ala454 0.02 Ala454→Thr (A454T)
Exon 16 nt 2369 G→A Thr698 0.12 —
Exon 19 nt 3029 G→A Glu918 0.07 —
Exon 23 nt 4142 T→C Phe1289 0.22 —
Exon 46 nt 6938 T→C His2221 0.46 —
Exon 47 nt 7213 (CAG)n 39UTR # —
Frequency as observed in 100 control chromosomes; #, seven alleles of (CAG)n were observed in the range between n 5 4 to n 5 14, with a
heterozygosity value of 0.75.
we also identified mutations in two out of four EA-2 S4 domains are considered to be the voltage sensors
of Ca21 channels and have a conserved, unusual patternfamilies (Table 3; Figure 5). In family CAN-191, a one
nucleotide deletion occurred at position 4073 (codon of positively charged arginine residues at every third
or fourth position, separated by hydrophobic residues1266) causing a frame shift and a premature stop in
exon 23, at codon 1333. A second EA-2 mutation was (Tanabe et al., 1987; Stea et al., 1995). The R192Q muta-
tion distorts this conserved higher order structure ren-detected in family CAN-26 inwhich a transition of G-to-A
of the conserved first nucleotide of intron 28 occurred, dering it plausible that this mutation compromises func-
tioning as a voltage sensor.predicted to cause aberrant splicing. So far, no muta-
tions were found in FHM family It-I, in the six sporadic The second missense mutation (T666M) was identified
in family US-P and is located in the pore-forming (P)hemiplegic migraine patients, and in two EA-2 families.
segment between IIS5 and IIS6 (Figure 3). Various obser-
vations have shown that these hairpin structures be-Discussion
tween each of the S5 and S6 segments in ion channels
together form the ion-selectivity filter of the pore andWe have isolated the CACNL1A4 gene, in which we
identified mutations in FHM and EA-2 patients, demon- present binding sites for toxins (Guy and Durell, 1996).
Alignment of protein sequences of different P segmentsstrating these paroxysmal disorders to be allelic. As
the CACNL1A4 gene encodes a brain-specific P/Q-type shows that some residues are conserved in many ion
channel genes (Guy and Durell, 1996). The T666M substi-Ca21 channel a1 subunit, FHM and EA-2 can now be
considered as cerebral ion channel disorders. Moreover, tution alters one of the conserved residues in the P
segment, which makes it likely that the T666M substitu-since FHM is part of themigraine spectrum, further eluci-
dation of this pathway will lead to new insights into the tion will affect the ion-selectivity or toxin binding ability
of the P/Q-type Ca21 channel.etiology of the more common types of migraine.
The remaining two missense mutations identified in
FHM families alter the S6 segment of the second andMissense Mutations in Familial
Hemiplegic Migraine the fourth repeat. The mutation in domain IIS6, the
V714A substitution, was identified in FHM family UK-B,Four different missense mutations were identified in five
unrelated FHM families (Table 3; Figure 4). One of these whereas the I1811L mutation, affecting domain IVS6,
was present in two unrelated FHM families (NL-A andmissense mutations occurred in two unrelated FHM
families on different haplotypes, strongly supporting re- US-C). The occurrence of I1811L in two FHM families
with a different chromosome 19p13 haplotype and thecurrent mutations rather than a founder effect.
In family It-II, a mutation was identified in the IS4 absence in 100 control chromosomes indicate that this
I1811L variant is due to recurrent mutations rather thandomain of CACNL1A4, substituting a positively charged
arginine with a neutral, nonpolar glutamine (R192Q). The a common founder effect, while this finding renders its
Table 3. CACNL1A4 Mutations in Families with FHM or EA-2
Disease Family Location Domain Nucleotide Change Consequence
FHM It-II exon 4 I S4 nt 850 Arg192→GlnG→A R192Q
(gain of SfcI site)
FHM US-P exon 16 P-segment nt 2272 Thr666→MetC→T T666M
FHM UK-B exon 17 II S6 nt 2416 Val714→AlaT→C V714A
(gain of Bbvl site)
FHM NL-A/US-C exon 36 IV S6 nt 5706 Ile1811→LeuA→C I1811L
(gain of MnII site)
EA-2 CAN-191 exon 22 III S1 nt 4073 frameshiftdeletion C STOP1294
(loss of NlaIV site)
EA-2 CAN-26 intron 24 splice site nt 427011 AC/gt→AC/atG→A aberrant
(loss of BsaAI site) splicing
Cell
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Figure 5. Mutation Detection in the CACNL1A4 Gene in EA-2 Fam-
ilies
Demonstration of EA-2 mutations by restriction site analysis of
CACNL1A4 PCR products: (A) one basepair deletion (DC4073) in CAN-
191 leads to loss of NlaIV restriction site in exon 22; (B) splice
site mutation in intron 24 is shown by loss of BsaAI site in family
Figure 4. Mutation Detection in the CACNL1A4 Gene in FHM Fam- CAN-26.
ilies
Detection of four CACNL1A4 missense mutations in five different
FHM families by restriction site (A, C, and D) or SSCP (B) analysis of
Premature Stops in Episodic Ataxia Type-2PCR products. All missense mutations cosegregate with the disease
The identification of different mutations that are pre-within the families. Restriction site analysis: (A) exon 4 mutation
dicted to disrupt the reading frame of CACNL1A4 in two(R192Q) in family It-II is recognized by SfcI digestion; control DNA
consisted of DNA mixture of three unrelated individuals, (C) mutation unrelated EA-2 patients provides strong evidence that
V714A in family UK-B leads to additional BbvI site, and (D), mutation CACNL1A4 is also involved in the pathogenesis of EA-2
I1811L in families NL-A and US-C is detected by gain of MnlI restric- (Table 3; Figure 5). In CAN-26, a basepairdeletion (DC4073)tion site. SSCP analysis: (B) aberrant SSCP conformers represent
in codon 1266 leads to a frame-shift in the putativecosegregation of T666M mutation within family US-P. Arrows indi-
translation product and encounters a stop codon in thecate positions of the aberrant bands in FHM affected individuals.
next exon (codon 1294). This frame-shift should yield a
truncated Ca21 channel a1 subunit consisting of repeat
I and II, and a small portion of repeat III (IIIS1).explanation as a rare polymorphism exceedingly un-
likely. The V714A and I1811L missense mutations do The G-to-A transition of the first nucleotide of intron
24 is affecting the highly conserved GT dinucleotide ofnot actually change theneutral-polar natureof the amino
acid residues, but they are located at nearly the same the intronic 59 splice junction. The brain-specific expres-
sion of CACNL1A4 precludes testing the hypothesis thatposition at the intracellular end of IIS6 and IVS6, while
the original residues are conserved in all Ca21 channel this mutation produces aberrantly spliced RNAs by re-
taining the intron or utilizing other cryptic 59 splice sites.a1 subunit genes described (Stea et al., 1995).
Cerebellar atrophy in FHM families has been reported
in z40% of chromosome 19-linked FHM families but is Molecular Mechanism of EA-2 and FHM
Identification of contrasting classes of mutations in EA-2not found in unlinked FHM families (Terwindt et al.,
1996). We identified the same mutation (I1811L) in two and FHM, premature stops and missense mutations,
respectively, suggests different molecular mechanismsdifferent FHM families, of which only one also displays
cerebellar atrophy in (some) affected family members. underlying the two disorders. The frame-shift and splice-
site mutations in EA-2 are predicted to yield a truncatedApparently other factors than this amino acid substitu-
tion further contribute to the phenotypic variability. Ca21 channel a1 subunit consisting of repeats I and II,
and a part of repeat III (IIIS1). These peptides are unlikelyThese factors may include genetic polymorphisms else-
where in the gene or at other channel-related loci and to form functional Ca21 channels and may either nega-
tively influence P/Q Ca21 channel assembly in the mem-the net effect of other ion channels on the polarity of
the cell membrane. brane (a dominant negative effect), or be unstable and
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cause haploinsufficiency. A decrease of channel density (Altura, 1985; Zhang et al., 1992), our findings may also
add to the growing evidence for involvement of magne-according to either mechanism may lead to episodes
of cerebellar dysfunction presenting as ataxia. sium in migraine pathophysiology. Magnetic resonance
spectroscopy studies suggest that intracellular brainThe four missense mutations identified in FHM sug-
gest a different mechanism. It is likely that both alleles magnesium is reduced in migraineurs and that the re-
gional distribution of brain magnesium is altered in pa-of the a1 subunit are expressed with the allele harboring
a missense mutation resulting in gain-of-function vari- tients with FHM (Ramadan et al., 1989). Furthermore,
preliminary clinical trial datasuggest that chronic admin-ants of this Ca21 channel a1 subunit. Such mutations
have been described e.g. in the a subunit of the skeletal istration of magnesium may reduce migraine attack fre-
quency (Peikert et al., 1996).muscle sodium channel causing hyperkalemic periodic
paralysis, paramyotonia congenita, and sodium channel Finally, Ca21 and other ion channels are important in
the mechanism of cortical spreading depression, whichmyotonias (Hudson et al., 1995; Cannon, 1996). Each of
these missense mutations codes for a substitution at is believed to initiate migraine attacks (Lauritzen, 1996).
Thus, impaired function of cerebral Ca21 channels mayhighly conserved residues, leading to an impaired inacti-
vation of the Na1-channel. This example also demon- facilitate the initiation of attacks.
Even though we have demonstrated a role for thisstrates that different mutations in a single gene may
result in marked phenotypic heterogeneity. chromosome 19p13 locus in z50% of FHM families
(Ophoff et al., 1994) and a contribution to common forms
of migraine (May et al., 1995), it is evident that additional
Implications for Migraine genes need to be identified to explain the full spectrum
Sib-pair analysis already showed significant involve- of FHM and migraine. The functional P/Q-type Ca21
ment of the 19p13 FHM locus in migraine with and with- channel is a multisubunit complex consisting of b, a2,
out aura (May et al., 1995). Therefore, the association of and d subunits in addition to the a1 subunit described
CACNL1A4 variants, notably the single missense variant here. Genes for those subunits and other interacting
(A454T) and the polymorphic trinucleotide (CAG) repeat proteins should be considered as potential candidate
in the 39 noncoding region (Table 2), should now be genes for non-chromosome 19-linked FHM and for mi-
investigated. The A454T variant, with an observed heter- graine with or without aura.
ozygosity of 0.02, is located in the intracellular loop In conclusion, our findings implicate the brain-specific
between IS6 and IIS1 (Figure 3). This region contains P/Q-type Ca21 channel a1-subunit gene onchromosome
a conserved a interaction domain (AID) that binds b 19p13.1 (CACNL1A4) in the pathogenesis of both EA-2
subunits (De Waard et al., 1996). The observed repeat and FHM, and most likely also of the more common
length of (CAG)n varied from n 5 4 to n 5 14 and did forms of migraine. Insight into the structure and function
not reach values of n $ 40 typical for the highly unstable of this gene will improve diagnosis and may provide a
expanded trinucleotide repeats in, for example, individu- rationale for the development of specific prophylactic
als affected by spinocerebellar ataxia type-1 (Orr et al., therapy for migraine and other paroxysmal cerebral dis-
1993) or Huntington’s disease (Huntington’s Disease orders.
Collaborative Research Group, 1993). Still, such a tri-
nucleotide repeat length may well affect, e.g., mRNA Experimental Procedures
stability or the splicing efficiency and may interact with
Subjectsthe transcript processing or translation. A minor change
Sixteen FHM patients wereselected, including eight individuals fromin mRNA stability may have a quantitative effect on the
four unrelated chromosome 19-linked FHM families (NL-A, UK-B,
P/Q-type Ca21 channels and may thus alter the threshold US-C [Ophoff et al., 1994], and US-P [Elliot et al., 1996]), two affected
for internal or external trigger factors. individuals from two small FHM families from Italy (It-I and -II), and
Identification of FHM and EA-2 as channelopathies six individuals with sporadic hemiplegic migraine (i.e., no other fam-
ily member was shown to suffer from attacks of hemiplegic mi-opens new avenues for the development of prophylactic
graine). In families NL-A and US-P cerebellar ataxia and/or nystag-treatment. Most currentmodels of migraine suggest that
mus is associated with FHM. An additional set of four subjects fromserotonin (5-hydroxytryptamine; 5-HT) plays a central
four unrelated EA-2 families linked to chromosome 19 was also
role in migraine pathophysiology (Ferrari and Saxena, included (CAN-25, -45, -191, -197). Fifty randomly collected individu-
1993). In migraine patients, 5-HT metabolism is dis- als from the Dutch population were used as a control to determine
turbed: interictal systemic 5-HT levels are reduced and the allele frequencies of polymorphic sites.
rise during attacks, possibly as a (failing) self-defense
Exon Trap Experimentsresponse (Ferrari et al., 1989). Effective specific acute
Exon trapping was performed according to Buckler et al. (1991). Inanti-migraine drugs all share the ability to stimulate neu-
brief, eight cosmids from the candidate region (LLNL no. 31563,
ronal and vascular 5-HT1 receptors, thereby, among 23883, 26540, 17498, 31583, 14268, 26432, 20618) were completely
other effects, inhibiting release of vasoactive neuropep- digested with BamHI, BglII, and BamHI/BglII. The pooled fragments
tides (Moskowitz, 1992; Ferrari and Saxena, 1995). Inter- were randomly cloned into the BamHI site of the pSPL3 vector.
Plasmid DNA was used to transfect COS1 cells. Total RNA wasestingly, P-type neuronal Ca21 channels mediate 5-HT
isolated from the COS1 cells 48 hr after transfection, cDNA wasrelease (Codignola et al., 1993). Dysfunction of such
synthesized, and PCR products (amplified using vector-specificchannels, due to missense mutations, and thus inappro-
primers) were subcloned (TA cloning kit, Invitrogen) and sequenced.
priate control of 5-HT release, may predispose patients
for migraine attacks or may impair their self-aborting cDNA Sequence
mechanism. Two fragments of cDNA sequences (based on exon trapping and
BLAST search, respectively) were amplified and used as probes forBecause Mg21 is known to interfere with Ca21 channels
Cell
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screening a human cerebellum cDNA library (Clontech). Amplimers
for PCR of the first probe (600 bp; containing trapped exons)
were forward 59-TAGCGAATTGCATCATCCTCGC-39 and reversed
59-CCACCCTTCCATGGTTATGC-39. The second probe (480 bp) was
amplified by forward primer 59-TGCGAGAGATGGGCAGAGAT-39
and reversed primer 59-TGGGCATAGCGGTCCTTGTC-39. Rather
than going through multiple rounds of hybridizations, the correct
inserts of positive plaques were amplified after a primary screening,
using a combination of cDNA- and vector-specific oligonucleotide
primers. Simultaneously, primers were designed based on se-
quences identical in rabbit (EMBL X57476) and rat (GenBank
M64373) cDNA. These primers were succesfully used for a direct
amplification of fragments of cDNA from total human cerebellum
cDNA; PCR products were cloned (TA cloning kit, InVitroGen) and
sequenced. Figure 6. Mutation Screening by Denaturing High Performance Liq-
uid Chromatography (DHPLC)
Northern Blot Analysis Chromatograms of DHPLC analysis of heterozygote PCR product
Northern blot was prepared containing total RNA (20 mg/lane) of at increasing mobile phase temperatures (578C–618C). Successful
several tissues from rhesus monkey (total brain, cerebellum, cortex, resolution of heteroduplex signal of exon 32 of family member of
hypothalamus, muscle, heart, kidney, liver) as well as total RNAfrom NL-A was accomplished at 618C.
human lymphocytes and mouse skin tissue. Total RNA was isolated
as previously described (Chomczynski and Sacchi, 1987). Hybridiza-
PCR product of at least one affected individual and one unaffectedtion was performed in Church buffer for 16 hr at 658C using a-32P-
control was digested with 3 U of appropriate restriction enzymelabeled cDNA probe 1 (section cDNA sequence). The blot was
(Table 3) in 20 ml reaction volume for 6 hr at 378C, according to thewashed at 658C and to a stringency of 0.33 SSC/0.1% SDS.
manufacturer’s instructions.
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